Valuation: Cogstate Limited

Market Cap 58Cr 40Cr 35Cr 34Cr 30Cr 57Cr 3.85TCr 401.05Cr 154.33Cr 1.97TCr 150.86Cr 147.57Cr 6.31TCr P/E 2027 *
26.9x
P/E 2028 * 21.6x
Enterprise Value 51Cr 36Cr 31Cr 30Cr 27Cr 51Cr 3.42TCr 356.45Cr 137.17Cr 1.75TCr 134.09Cr 131.16Cr 5.61TCr EV / Sales 2027 *
4.8x
EV / Sales 2028 * 4.05x
Free-Float
56.35%
Yield 2027 *
1.46%
Yield 2028 * 1.72%
1 day-0.29%
1 week+3.03%
Current month-0.29%
1 month+10.39%
3 months+24.54%
6 months+56.68%
Current year+50.44%
1 week 3.23
Extreme 3.23
3.45
1 month 2.95
Extreme 2.95
3.5
Current year 2.01
Extreme 2.01
3.5
1 year 1.75
Extreme 1.75
3.5
3 years 0.8
Extreme 0.795
3.5
5 years 0.8
Extreme 0.795
3.5
10 years 0.16
Extreme 0.155
3.5
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 17/12/1999
Chief Executive Officer - 01/12/2005
Director of Finance/CFO - 01/02/2021
Director TitleAgeSince
Director/Board Member - 01/03/2011
Chairman 67 03/11/2009
Director/Board Member - 20/01/2017
Date Insider Type Main position Quantity % Market Cap. Importance
20/05/26 Buy

Director

3,600 0.0021%
20/05/26 Buy

Director

430 0.0003%
15/04/26
Myer & Myer Pty Ltd.
SellCompany 99,74,569 5.8334%
Change 5-day change 1-year change 3-year change Capi.($)
-0.29%+3.03%+55.25%+122.95% 40Cr
+4.16%-0.36%+49.37%+94.17% 7.45TCr
-0.61%+0.81%+27.25%+80.21% 6.01TCr
-2.54%-1.65%+4.86%+33.32% 4.82TCr
-2.05%-4.00%+29.55%+36.17% 4.43TCr
+2.52%+4.69%+356.26%+699.54% 4.4TCr
-0.99%+0.83%+8.29%+103.33% 4.16TCr
+3.32%+3.49%+11.18%+51.23% 3TCr
+4.77%+6.16%+36.77%+22.78% 2.93TCr
-3.18%-9.67%-25.45%+332.79% 2.49TCr
Average +0.53%+2.10%+55.33%+157.65% 3.97TCr
Weighted average by Cap. +0.75%+1.83%+59.60%+152.73%

Financials

2027 *2028 *
Net sales 11Cr 7.44Cr 6.55Cr 6.21Cr 5.6Cr 11Cr 713.16Cr 74Cr 29Cr 364.58Cr 28Cr 27Cr 1.17TCr 12Cr 8.52Cr 7.5Cr 7.11Cr 6.42Cr 12Cr 817.15Cr 85Cr 33Cr 417.75Cr 32Cr 31Cr 1.34TCr
Net income 2.17Cr 1.51Cr 1.33Cr 1.26Cr 1.14Cr 2.15Cr 144.89Cr 15Cr 5.8Cr 74Cr 5.67Cr 5.55Cr 237.47Cr 2.69Cr 1.87Cr 1.65Cr 1.56Cr 1.41Cr 2.65Cr 179.25Cr 19Cr 7.18Cr 92Cr 7.02Cr 6.87Cr 293.79Cr
Net Debt -6.42Cr -4.47Cr -3.93Cr -3.73Cr -3.36Cr -6.34Cr -428.33Cr -45Cr -17Cr -218.97Cr -17Cr -16Cr -702.03Cr -8.18Cr -5.69Cr -5.01Cr -4.75Cr -4.28Cr -8.07Cr -545.3Cr -57Cr -22Cr -278.77Cr -21Cr -21Cr -893.75Cr
Logo Cogstate Limited
Cogstate Limited is a neuroscience technology company optimizing brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare. Its principal activities are the creation, validation, and commercialization of digital brain health assessments; and design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Administration. In the Clinical Trials segment, the technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical, and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians and/or hospitals to assess cognitive decline.
Employees
160
Date Price Change Volume
01/26/01 A$3.400 -0.29% 1,27,382
30/26/30 A$3.410 0.00% 14,36,554
29/26/29 A$3.410 +3.02% 2,18,386
28/26/28 A$3.310 -1.78% 2,59,372
25/26/25 A$3.370 +4.01% 4,74,110
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.400AUD
Average target price
4.312AUD
Spread / Average Target
+26.83%

Quarterly revenue - Rate of surprise